BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wilhelmsen M, Kring T, Jorgensen LN, Madsen MR, Jess P, Bulut O, Nielsen KT, Andersen CL, Nielsen HJ. Determinants of recurrence after intended curative resection for colorectal cancer. Scand J Gastroenterol. 2014;49:1399-1408. [PMID: 25370351 DOI: 10.3109/00365521.2014.926981] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 van der Stok EP, Spaander MCW, Grünhagen DJ, Verhoef C, Kuipers EJ. Surveillance after curative treatment for colorectal cancer. Nat Rev Clin Oncol 2017;14:297-315. [DOI: 10.1038/nrclinonc.2016.199] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 12.3] [Reference Citation Analysis]
2 Ward RD, Amorim B, Li W, King J, Umutlu L, Groshar D, Harisinghani M, Catalano O. Abdominal and pelvic 18F-FDG PET/MR: a review of current and emerging oncologic applications. Abdom Radiol 2021;46:1236-48. [DOI: 10.1007/s00261-020-02766-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Thomas J, Ohtsuka M, Pichler M, Ling H. MicroRNAs: Clinical Relevance in Colorectal Cancer. Int J Mol Sci 2015;16:28063-76. [PMID: 26602923 DOI: 10.3390/ijms161226080] [Cited by in Crossref: 79] [Cited by in F6Publishing: 79] [Article Influence: 11.3] [Reference Citation Analysis]
4 Dos Santos IL, Penna KGBD, Dos Santos Carneiro MA, Libera LSD, Ramos JEP, Saddi VA. Tissue micro-RNAs associated with colorectal cancer prognosis: a systematic review. Mol Biol Rep 2021;48:1853-67. [PMID: 33598796 DOI: 10.1007/s11033-020-06075-1] [Reference Citation Analysis]
5 Suarez-Weiss KE, Herold A, Gervais D, Palmer E, Amorim B, King JD, Weier L, Shahein T, Bernstine H, Domachevsk L, Cañamaque LG, Herrmann K, Umutlu L, Groshar D, Catalano OA. Hybrid imaging of the abdomen and pelvis.Radiologe. 2020;60:80-89. [PMID: 32424463 DOI: 10.1007/s00117-020-00661-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Amorim BJ, Hong TS, Blaszkowsky LS, Ferrone CR, Berger DL, Bordeianou LG, Ricciardi R, Clark JW, Ryan DP, Wo JY, Qadan M, Vangel M, Umutlu L, Groshar D, Cañamaques LG, Gervais DA, Mahmood U, Rosen BR, Catalano OA. Clinical impact of PET/MR in treated colorectal cancer patients. Eur J Nucl Med Mol Imaging 2019;46:2260-9. [PMID: 31359108 DOI: 10.1007/s00259-019-04449-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
7 Zawiah M, Yousef AM, Kadi T, Yousef M, Majdalawi K, Al-Yacoub S, Al-Hiary R, Tantawi D, Mukred R, Ajaj AR. Early disease relapse in a patient with colorectal cancer who harbors genetic variants of DPYD, TYMS, MTHFR and DHFR after treatment with 5-fluorouracil-based chemotherapy. Drug Metab Pers Ther 2018;33:201-5. [PMID: 30207288 DOI: 10.1515/dmpt-2018-0012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Suarez-Weiss KE, Herold A, Gervais D, Palmer E, Amorim B, King JD, Weier L, Shahein T, Bernstine H, Domachevsk L, Cañamaque LG, Umutlu L, Herrmann K, Groshar D, Catalano OA. [Hybrid imaging of the abdomen and pelvis. German version]. Radiologe 2020;60:394-404. [PMID: 32232543 DOI: 10.1007/s00117-020-00660-y] [Reference Citation Analysis]
9 Liu SS, Shi Q, Li HJ, Yang W, Han SS, Zong SQ, Li W, Hou FG. Right- and left-sided colorectal cancers respond differently to traditional Chinese medicine. World J Gastroenterol 2017; 23(42): 7618-7625 [PMID: 29204061 DOI: 10.3748/wjg.v23.i42.7618] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
10 Friedenreich CM, Shaw E, Neilson HK, Brenner DR. Epidemiology and biology of physical activity and cancer recurrence. J Mol Med (Berl). 2017;95:1029-1041. [PMID: 28620703 DOI: 10.1007/s00109-017-1558-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
11 Chen Y, Qin Y, Dai M, Liu L, Ni Y, Sun Q, Li L, Zhou Y, Qiu C, Jiang Y. IBSP, a potential recurrence biomarker, promotes the progression of colorectal cancer via Fyn/β-catenin signaling pathway. Cancer Med 2021;10:4030-45. [PMID: 33987980 DOI: 10.1002/cam4.3959] [Reference Citation Analysis]
12 Kovács BZ, Puskás LG, Nagy LI, Papp A, Gyöngyi Z, Fórizs I, Czuppon G, Somlyai I, Somlyai G. Blocking the Increase of Intracellular Deuterium Concentration Prevents the Expression of Cancer-Related Genes, Tumor Development, and Tumor Recurrence in Cancer Patients. Cancer Control 2022;29:107327482110689. [DOI: 10.1177/10732748211068963] [Reference Citation Analysis]
13 Shi Q, Liu S, Li W, Zong S, Han S, Yang W, Li H, Hou F. Exploring the medication duration based on the effect of traditional Chinese medicine on postoperative stage I-III colorectal patients: a retrospective cohort study. Oncotarget. 2017;8:13488-13495. [PMID: 28086238 DOI: 10.18632/oncotarget.14567] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wilhelmsen M, Christensen IJ, Rasmussen L, Jørgensen LN, Madsen MR, Vilandt J, Hillig T, Klaerke M, Nielsen KT, Laurberg S, Brünner N, Gawel S, Yang X, Davis G, Heijboer A, Martens F, Nielsen HJ. Detection of colorectal neoplasia: Combination of eight blood-based, cancer-associated protein biomarkers. Int J Cancer 2017;140:1436-46. [PMID: 27935033 DOI: 10.1002/ijc.30558] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]